RFP
EBS icon

Root Financial Partners’s Emergent Biosolutions EBS Stock Holding History

Root Financial Partners’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-274
Closed -$2.27K – 1189
2026
Q1 		$2.27K Buy
+274
New +$2.84K ﹤0.01% 2265

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
OHA
Oak Hill Advisors New York $701M AUM 78.4% 1-Year Est. Return

Root Financial Partners's EBS Position: Q2 2026 in Review

Root Financial Partners sold out of Emergent Biosolutions (EBS) in Q2 2026, closing a stake of 274 shares — an estimated $2.27K sold.

Root Financial Partners first reported a position in EBS in Q1 2026 and held it in 1 quarter. The position peaked at $2.27K in Q1 2026. 194 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

  • Root Financial Partners reported no remaining Emergent Biosolutions position as of Q2 2026 after selling out during the quarter.
  • Root Financial Partners sold 274 Emergent Biosolutions shares in Q2 2026, an estimated $2.27K.
  • Root Financial Partners first reported a position in Emergent Biosolutions in Q1 2026 and held it in 1 quarter.
  • Root Financial Partners's Emergent Biosolutions position peaked at $2.27K in Q1 2026.
  • 194 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on Root Financial Partners's 13F filing for Q2 2026, filed 29 Jul 2026.